Is AngioDynamics, Inc. (ANGO) Overvalued?
We dive into why AngioDynamics, Inc. (ANGO) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
Jenna Brashear
Rosalio Madrigal
| Share Statistics | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $648.1 | $373.7 | 40% |
|
| Shares Out (Mil) | 41.7 | 40.8 | 43% |
|
| Institutional Ownership | 88.6% | 83.6% | 56% |
|
| Float (Mil) | 31.8 | 34.7 | 37% |
|
| Beta | 0.34 | 0.88 | 20% |
|
| Avg Daily Volume (000s) | 391 | 266 | 56% |
|
| Price Change (52-week) |
47.2% | 62.5% | 81% |
|
| Growth | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.9% | 11.8% | 23% |
|
| Net Income (5yr) | (3.1%) | (5.8%) | 36% |
|
| EPS (5yr) | (1.5%) | 10.4% | 29 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 20.8% | (15.5%) | 80% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 2 | |
| Current EPS | ($0.113) | ($0.267) | ($0.045) | |
| Month Ago EPS | ($0.113) | ($0.267) | ($0.045) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.097) | ($0.220) | ($0.030) | |
| Year/Year Chg | (58.8%) | (69.8%) | (124.9%) | |
| Financials | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $320 | $119 | 36% |
|
| Net Income (TTM) (Mil) | ($37) | ($9) | 19% |
|
| EPS (TTM) | ($0.885) | ($0.400) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | $3 | ($3) | 35% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $1 | 38% |
|
| Long-Term Debt (Q1) (Mil) | $9 | $23 | 28% |
|
| Enterprise Value (Q1) (Mil) | $542 | $371 | 35% |
|
| Valuation | ANGO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.82 | 2.80 | 73% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | ANGO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.6% | 58.3% | 67% |
|
| Net Margin | (11.5%) | (6.9%) | 20% |
|
| ROA | (13.4%) | (12.7%) | 23% |
|
| ROE | (20.8%) | (12.3%) | 23% |
|
| Liabilities to Assets | 36.1% | 46.0% | 27% |
|
| F-Score | 4 | 4 | 33% |
|
AngioDynamics, Inc. did not pass any screens on 9/15/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors